Samsung Bioepis Uk Limited competitive analysis

Explore patent oppositions filed by Samsung Bioepis Uk Limited against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 20, 2026
Patent NumberTitleApplicantOpposition Date
Liquid Pharmaceutical CompositionARES TRADINGJul 22, 2020
Pharmaceutical Anti-Tnf-Alpha Antibody FormulationRICHTER GEDEON NYRTJun 19, 2019
Liquid Pharmaceutical CompositionARES TRADINGMar 26, 2019

Explore Samsung Bioepis Uk Limited's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 20, 2026
Patent NumberPublication DateTitleTotal Oppositions
Apr 3, 2024Control Of Protein Glycosylation By Culture Medium Supplementation And Cell Culture Process Parameters1

Latest PTAB cases involving Samsung Bioepis Uk Limited

Discover the latest PTAB cases involving Samsung Bioepis Uk Limited, highlighting their recent legal challenges and patent disputes.

Last updated on: Aug 25, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Samsung Bioepis Uk Limited

IPR2025-00176Nov 20, 2024SAMSUNG BIOEPIS UK LIMITEDREGENERON PHARMACEUTICALSInstitution Denied
IPR2023-01312Aug 18, 2023SAMSUNG BIOEPIS UK LIMITEDREGENERON PHARMACEUTICALSTerminated-Adverse Judgment
IPR2023-01103Jun 21, 2023SAMSUNG BIOEPIS UK LIMITEDJANSSEN BIOTECHTerminated-Settled
IPR2023-01069Jun 16, 2023SAMSUNG BIOEPIS UK LIMITEDALEXION PHARMACEUTICALSTerminated-Settled
IPR2023-01070Jun 16, 2023SAMSUNG BIOEPIS UK LIMITEDALEXION PHARMACEUTICALSTerminated-Settled
IPR2023-00998May 31, 2023SAMSUNG BIOEPIS UK LIMITEDALEXION PHARMACEUTICALSTerminated-Settled
IPR2023-00999May 31, 2023SAMSUNG BIOEPIS UK LIMITEDALEXION PHARMACEUTICALSTerminated-Settled
IPR2023-00933May 18, 2023SAMSUNG BIOEPIS UK LIMITEDALEXION PHARMACEUTICALSTerminated-Settled
IPR2023-00884Apr 27, 2023SAMSUNG BIOEPIS UK LIMITEDREGENERON PHARMACEUTICALSTerminated-Adverse Judgment
IPR2023-00739Mar 26, 2023SAMSUNG BIOEPIS UK LIMITEDREGENERON PHARMACEUTICALSTerminated-Adverse Judgment

Peer Comparison New

IP litigation analysis comparing Samsung Bioepis Uk Limited with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 20, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
SAMSUNG BIOEPIS UK LIMITED3118 -
ALEXION PHARMACEUTICALS39 - 8
GENENTECH - 115 - 66
REGENERON PHARMACEUTICALS38128932